Standard BioTools Inc.

LAB

$0.68

+0.36%

N/A+$0.00

Atención médica

Medicina - Especialidades

NASDAQ

Negociación activa

Standard BioTools Inc., junto con sus subsidiarias, desarrolla, fabrica y vende una gama de instrumentos, consumibles y servicios a científicos e investigadores ...

Transacciones de insiders de LAB

Compras (A)

Since Jun 18, 2026

Ventas (D)

Since Jun 18, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Aug 20, 2026	Mackay Sean	officer: SVP & Chief Business Officer	Common Stock	D	25,729	$0.67
Aug 20, 2026	Kim Hanjoon Alex	officer: Chief Financial Officer	Common Stock	D	28,195	$0.67
Aug 20, 2026	Egholm Michael	director, officer: President & CEO	Common Stock	D	97,627	$0.67
Aug 3, 2026	Egholm Michael	director, officer: President & CEO	Common Stock	D	362,625	$0.87
Jul 23, 2026	Kim Hanjoon Alex	officer: Chief Financial Officer	Common Stock	D	202,476	$0.90

Resumen de trading de insiders

Compras (A)

Ventas (D)

Acciones compradas totales

1,138,039

Acciones vendidas totales

716,652

Actividad mensual de insiders

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Por cargo - Acciones

Eje X: acciones, ordenado por acciones totales desc.

Por cargo - Conteos

Eje X: conteos, ordenado por conteos A+D desc.

Personas clave: actividad de compra/venta y precio

Egholm Michael

director, officer: President & CEO • 2 transacciones

Mackay Sean

officer: SVP & Chief Business Officer • 2 transacciones

Kim Hanjoon Alex

officer: Chief Financial Officer • 2 transacciones

Carey Thomas D.

director • 2 transacciones

Tabla de transacciones

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio	Valor
Aug 20, 2026	Mackay Sean	officer: SVP & Chief Business Officer	Common Stock	D	25,729	$0.67	$17,289.89
Aug 20, 2026	Kim Hanjoon Alex	officer: Chief Financial Officer	Common Stock	D	28,195	$0.67	$18,947.04
Aug 20, 2026	Egholm Michael	director, officer: President & CEO	Common Stock	D	97,627	$0.67	$65,605.34
Aug 3, 2026	Egholm Michael	director, officer: President & CEO	Common Stock	D	362,625	$0.87	$314,758.50
Jul 23, 2026	Kim Hanjoon Alex	officer: Chief Financial Officer	Common Stock	D	202,476	$0.90	$181,216.02
Jun 20, 2026	Mackay Sean	officer: SVP & Chief Business Officer	Common Stock	A	500,000	—	—
Jun 18, 2026	Carey Thomas D.	director	Common Stock	A	99,116	—	—
Jun 18, 2026	Carey Thomas D.	director	Stock Option (Right to buy)	A	263,884	$0.83	$218,944.55
Jun 18, 2026	Witney Frank	director	Common Stock	A	99,116	—	—
Jun 18, 2026	Witney Frank	director	Stock Option (Right to buy)	A	175,923	$0.83	$145,963.31

Supply Chain de LAB

RELATIONS

Upstream

Revvity Inc. (BioLegend)NYSE:RVTYHamamatsu Photonics K.K.TSE:6965Various single/sole-source component suppliers (undisclosed)Rare earth metal isotope suppliers (undisclosed)Microfluidic chip raw material suppliers (undisclosed)Rare earth mining and processing companies

Downstream

Olink (part of Thermo Fisher Scientific Inc.)NYSE:TMONext Gen Diagnostics (NGD)Illumina Inc.NASDAQ:ILMNDKSH Holding AGSIX:DKSHATCG LimitedDHSI (China)AIRIX Corp. (Japan)Visiopharm (acquired by Grundium May 2026)

Proxies

Thermo Fisher Scientific Inc.NYSE:TMO Bio-Rad Laboratories Inc.NYSE:BIO Bruker CorporationNASDAQ:BRKR Revvity Inc.NYSE:RVTY Illumina Inc.NASDAQ:ILMN Quanterix CorporationNASDAQ:QTRX

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal